Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics

Go back to Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics
Xenetic Biosciences, Inc. (NASDAQ: XBIO) Delayed: 2.98 +0.21 (7.58%)
Previous Close $2.77    52 Week High $5.20 
Open $2.81    52 Week Low $0.21 
Day High $3.10    P/E N/A 
Day Low $2.81    EPS $-0.01 
Volume 85,434